ストックスクリーナーアプリを入手
463.28
2.24%
10.13
アフターアワーズ：
463.28
前日終値:
$453.15
開ける：
$457.33
24時間の取引高:
227.80K
Relative Volume:
0.95
時価総額：
$6.15B
収益：
$2.54B
当期純損益:
$259.78M
株価収益率:
25.25
EPS:
18.3497
ネットキャッシュフロー:
$377.12M
1週間 パフォーマンス:
+6.19%
1か月 パフォーマンス:
+5.93%
6か月 パフォーマンス:
+7.20%
1年 パフォーマンス:
-16.66%
1日の値動き範囲:
$452.53
$463.28
1週間の範囲:
$428.12
$463.28
52週間の値動き範囲:
$365.20
$562.76
Chemed Corp Stock (CHE) Company Profile
Compare CHE vs HCA, THC, DVA, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
463.28 | 6.02B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
391.68 | 85.84B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
189.00 | 15.84B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
217.04 | 13.69B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.24 | 12.49B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
101.33 | 9.89B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | ダウングレード | Jefferies | Buy → Hold |
| 2025-09-02 | アップグレード | Jefferies | Hold → Buy |
| 2025-07-25 | 開始されました | Jefferies | Hold |
| 2020-03-11 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | 繰り返されました | BofA/Merrill | Buy |
| 2018-10-12 | 開始されました | BofA/Merrill | Buy |
| 2017-08-28 | 開始されました | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | 繰り返されました | Oppenheimer | Outperform |
| 2015-10-26 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | 繰り返されました | Oppenheimer | Outperform |
| 2015-07-27 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | 繰り返されました | Oppenheimer | Outperform |
| 2014-09-23 | 繰り返されました | Oppenheimer | Outperform |
| 2014-06-10 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | 繰り返されました | Oppenheimer | Outperform |
| 2013-09-10 | 繰り返されました | Deutsche Bank | Hold |
| 2011-03-04 | 繰り返されました | Barclays Capital | Underweight |
| 2011-02-17 | 繰り返されました | Oppenheimer | Outperform |
| 2011-02-17 | 繰り返されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Chemed Corp (CHE) 最新ニュース
Should You Hold Chemed Stock in Your Portfolio Now? - Yahoo Finance
Chemed Corporation Actuals & Estimates (NYSE:CHE) - TradingView
Enterprise value to EBIT forward of Chemed Corp – NYSE:CHE - TradingView
Price to sales forward of Chemed Corp – NYSE:CHE - TradingView
Price to earnings forward of Chemed Corp – NYSE:CHE - TradingView
Enterprise value to revenue forward of Chemed Corp – NYSE:CHE - TradingView
Enterprise value to EBITDA forward of Chemed Corp – NYSE:CHE - TradingView
Behavioral Patterns of CHE and Institutional Flows - Stock Traders Daily
VITAS Healthcare Hospice Services from Chemed Corpquiet support for complex end-of-life care in t - Ad-hoc-news.de
Chemed Corp (CHE) Stock Analysis: Evaluating Its Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Chemed Corp (CHE) Institutional Confidence - TradingKey
Chemed StockLong-term hospice and plumbing model under review - Ad-hoc-news.de
Is Chemed (NYSE:CHE) Ready For A Valuation Rebound? - Kalkine Media
Quietly essential in a crisis, Roto-Rooter Water Restoration goes beyond clogged drains - Ad-hoc-news.de
Chemed Corp (CHE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Chemed Corp (CHE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Chemed Corp (CHE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Chemed Corp (CHE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Chemed Corp (CHE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Chemed Corp (CHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Chemed Corp (CHE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Chemed Corp (CHE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Chemed (CHE) Stock Valuation Check After Recent Mixed Performance And Undervaluation Debate - Yahoo Finance
Epoch Investment Partners Inc. Has $137.95 Million Stock Position in Chemed Corporation $CHE - MarketBeat
(CHE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Director Andrea Lindell Sells 1,347 Shares of Chemed Corp (CHE) - GuruFocus
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. By Investing.com - Investing.com South Africa
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. - Investing.com
Director Lindell sells 1,347 Chemed (NYSE: CHE) shares at $447.33 - Stock Titan
Roto-Rooter Services Company Acquires South Texas Franchise for $12 Million - Quiver Quantitative
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas - GlobeNewswire
Chemed Corp (CHE) Stock Analysis: A Robust Healthcare Play With Solid Financial Metrics - DirectorsTalk Interviews
ETFs Investing in Chemed Corporation Stocks - TradingView
VITAS CEO: CMS’ National Moratorium Disappointing - Hospice News
TD Asset Management Inc Has $138.86 Million Stock Holdings in Chemed Corporation $CHE - MarketBeat
Activist Barington targets healthcare firm Chemed - MSN
Chemed Corp (CHE) Moves Higher as Stock Tests Technical Resistance LevelsComposite Profile - newsline.com
Activist Barington Targets Healthcare Firm Chemed - Bloomberg.com
Chemed edges higher on report activist Barington has taken a stake - Seeking Alpha
CHE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (CHE) Movements Inform Risk Allocation Models - Stock Traders Daily
Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside - DirectorsTalk Interviews
CHE Technical Analysis & Stock Price Forecast - Intellectia AI
Chemed director Walsh sells $218,915 in stock By Investing.com - Investing.com Australia
Chemed Corp (CHE) Shares Fall 3.1% -- What GF Score of 78 Tells Investors - GuruFocus
Chemed director Walsh sells $218,915 in stock - Investing.com
Chemed (NYSE: CHE) director sells 500 shares in open-market trade - Stock Titan
CHE Q1 2026 Earnings: EPS Beats Estimates by 5.5%Pre-Earnings Drift - thelegaladvocate.com
Chemed Corp (CHE) Edges Higher Amid Steady Trading: Key Levels to WatchMA Crossover - The Legal Advocate
Chemed Corp (CHE) Q1 2026 Earnings: EPS Beats Expectations Amid Strong Operational PerformanceRevenue Surprise History - The Legal Advocate
Chemed Corp (CHE) Holds Steady Near Support Amid Narrow Trading RangeSupply Zone - The Legal Advocate
Chemed Corp (CHE) 財務データ
収益
当期純利益
現金流量
EPS
2.97%
1.62%
大文字化:
|
ボリューム (24 時間):